Search Results
Jun 09, 2026, 08:00 ET Matica Biotechnology announces engagement by University Health Network (UHN) to supply cGMP Manufacturing of IL-10 Adenoviral Therapy for Lung Transplantation
9, 2026 /PRNewswire/ -- Matica Biotechnology, Inc. ("Matica Bio"), a leading viral vector contract development and manufacturing organization (CDMO) specializing in advanced therapies, is pleased to announce its engagement with University Health Network (UHN). The agreement includes cGMP
More news about: Matica Biotechnology, Inc.
Jun 08, 2026, 16:17 ET CAREstream America introduces new era of science-backed innovation to deliver a new standard of quality to the US aesthetic market
capabilities in cell therapy, spanning from treatment development to Cell and Gene Therapy Contract Development and Manufacturing Organization (CGT CDMO) services. The group also operates Asia-Pacific's largest medical network, with 96 medical institutions across 7 countries, including South Korea, the
More news about: CAREstream America
Jun 08, 2026, 04:09 ET WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards
please visit: www.wuxibiologics.com.*The winner of the "2026 Biologics CDMO of the Year" (Large CDMOs) (Life Science Connect / Outsourced Pharma)*The winner of the "2026 Best Contract Development & Manufacturing
More news about: WuXi Biologics
Jun 05, 2026, 15:15 ET SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver
specializing in probiotics, postbiotics, and microbiome-based health solutions. With more than 25 years of R&D expertise and a fully integrated CDMO platform, the company partners with over 600 brands across 35 countries. SynbioTech develops clinically validated ingredients for healthy aging, muscle
More news about: SYNBIO TECH INC.
Jun 04, 2026, 22:45 ET WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility
positive social and environmental impacts and promote responsible practices that empower the entire value chain.*The winner of the "2026 Biologics CDMO of the Year" (Large CDMOs) The winner of the "2026 Best Contract Development & Manufacturing Organization Award" (ABEA)ContactsBusiness
More news about: WuXi Biologics
Jun 04, 2026, 10:30 ET Made Scientific and Pluristyx Launch Integrated iPSC Development & Manufacturing Partnership to Advance Next-Generation iPSC-derived Cell Therapies
manufacturing organization (CDMO) specializing in the development, manufacturing, and release of autologous and allogeneic cell therapy products for clinical- and commercial-supply. Headquartered in Princeton, New Jersey, Made Scientific combines the agility of a specialist CDMO with the deep technical
More news about: Made Scientific, Inc.
Jun 04, 2026, 10:17 ET Breckenridge announces launch of Tofacitinib Tablets, generic equivalent of Xeljanz® by Pfizer
Towa Pharmaceutical Italy, Spain, and Portugal, with offices in Milan, Barcelona, and Lisbon; and Towa 2B, which operates globally and includes the CMO/CDMO business line, maximizing the potential of its production capabilities. With more than 1.080 employees worldwide, the company is establishing itself
More news about: Breckenridge Pharmaceutical, Inc.
Jun 04, 2026, 08:30 ET Stronger Together, Shaping the Future | WuXi XDC and BioDlink Successfully Concluded 2026 Open Day
perspectives from biotechnology partners. Dr. Junhua Qiao, CTO of GenSci shared insights on effective collaboration models between biotech companies and CDMO partners, drawing on experience from both biotech and biopharma environments. Dr. Yu Zhang, CMC Head of DualityBio, analyzed the trends of the
More news about: BioDlink Biopharm Co., Ltd.
Jun 04, 2026, 06:00 ET Scispot Raises $8M Series A to Help Life Sciences Labs Move Faster
Scispot is already used by 100+ labs across biotech, pharma, diagnostics, genomics, CRO/CDMO, bioproduction, biobanking, and testing workflows. The company supports 250+ instrument types, 1000+ experiments per month, and millions of samples
More news about: Scispot
Jun 03, 2026, 23:36 ET MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Study with Confirmatory Evidence BLA Filing Strategy for CARTISTEM® in the U.S.
research and clinical development of allogeneic cell therapy assets, cord blood banking, and cell and gene therapy contract development and manufacturing (CDMO) business portfolios. MEDIPOST successfully commercialized the world's first regulatory-approved (2012) allogeneic human umbilical cord blood-derived
More news about: MEDIPOST
Jun 03, 2026, 11:00 ET Persist AI Teams up with Microsize and Micromacinazione (Micmac) to Launch First-of-Its-Kind Early-Stage "Micromill" Formulation Platform, Enabling Drug Development Decision With Milligrams of API
means shorter cycle times and less guess-work during the scale-up process.About MicrosizeMicrosize is a US-based pharmaceutical CDMO and a pioneer in micronization technology, with over 30 years of experience and hundreds of APIs processed across thousands of campaigns. Operating
More news about: Persist AI Formulations
Jun 03, 2026, 09:23 ET ProBio and GCP ClinPlus Partner to Accelerate Clinical Trials in China
Development and Clinical ExecutionThis collaboration unites ProBio Inc.'s deep expertise in biologics and cell and gene therapy (CGT) CDMO services with GCP ClinPlus's robust capabilities in clinical trial execution and site management across China. The combined offering supports cutting-edge
More news about: ProBio Inc.
Jun 03, 2026, 09:00 ET PBI-Gordon Companies Names Kent Luther Vice President of Sales and Commercial Operations for Pegasus Laboratories
and Sē•Qual™ brands.In addition to its animal health products, Pegasus operates as aa full-service Contract Development and Manufacturing Organization (CDMO), providing development and manufacturing, and turn-key technical services its FDA-registered facility that complies with current Good Manufacturing
More news about: PBI-Gordon Companies, Inc.
Jun 02, 2026, 22:35 ET WuXi Biologics Named to CDP Supplier Engagement Assessment A List for the Second Consecutive Year
visit: www.wuxibiologics.com.*The winner of the "2026 Biologics CDMO of the Year" (Large CDMOs)*The winner of the "2026 Best Contract Development & Manufacturing Organization Award"(ABEA)ContactsESG
More news about: WuXi Biologics
Jun 02, 2026, 08:01 ET Stevenson Search Partners and HAVEN Unite to Launch New Human Capital Platform: Tidemark Talent Solutions
Executive Search and On-Demand Talent Solutions advisor serving the global biotechnology, pharmaceutical, medical technology, health technology and CRO/CDMO sectors. With offices in the U.S. and U.K., Stevenson specializes in identifying and delivering talent that drives innovation across the life sciences
More news about: Tidemark Talent Solutions
Jun 02, 2026, 08:00 ET Phosphorex Names John Rigg Chairman of the Board
HOPKINTON, Mass., June 2, 2026 /PRNewswire/ -- Phosphorex, a drug delivery-focused CDMO specializing in lipid nanoparticles, polymeric nanoparticles, and polymeric microspheres, has named John Rigg Chairman of its Board of Directors. Rigg
More news about: Phosphorex LLC
Jun 01, 2026, 10:04 ET Made Scientific Selected as Manufacturer for Columbia University's Autologous and Allogeneic NOVAKnee Program - a First-in-Class Living Biologic Total Knee Replacement
manufacturing organization (CDMO) specializing in the development, manufacturing, and release of autologous and allogeneic cell therapy products for clinical and commercial supply. Headquartered in Princeton, New Jersey, Made Scientific combines the agility of a specialist CDMO with the deep technical expertise
More news about: Made Scientific, Inc.
Jun 01, 2026, 09:00 ET Metabolic Supply Group and Murphy Medical Solutions Announce Strategic Partnership and Launch of Pharmacy Network Access, Powered by MSG
healthcare and wellness clinics nationwide with high-quality compounds and dependable operational support. With access to 503A/503B pharmacy options, CDMO manufacturing, rigorous third-party testing, attorney oversight, and robust clinical education, Murphy Medical helps clinics increase revenue and serve
More news about: Metabolic Supply Group
May 29, 2026, 16:11 ET CordenPharma adquire a AmbioPharm para expandir a capacidade global de produção de APIs peptídicas
/PRNewswire/ -- CordenPharma, uma das principais organizações globais de desenvolvimento e fabrico por contrato (CDMO), anunciou hoje ter celebrado um acordo para adquirir a AmbioPharm, uma CDMO de APIs peptídicas com sede nos EUA.
More news about: CordenPharma
May 29, 2026, 16:05 ET CordenPharma acquisisce AmbioPharm per espandere la capacità globale delle API peptidiche
CordenPharma, una delle principali organizzazioni a livello globale di sviluppo e produzione a contratto (CDMO), annuncia oggi di aver stipulato un accordo per l'acquisizione di AmbioPharm, un peptide API CDMO con sede negli Stati Uniti.
More news about: CordenPharma
May 29, 2026, 11:22 ET Veeva Quality Cloud optimiert die Fertigungsabläufe bei Kindeva
Global CDMO wird seine Standorte auf einer einheitlichen Qualitätsplattform zusammenführen, um die Effizienz und Skalierbarkeit zu steigernBARCELONA, Spanien, 28. Mai 2026 /PRNewswire/ --
More news about: Veeva Systems
May 29, 2026, 10:49 ET Veeva Quality Cloud optimise les opérations de fabrication de Kindeva
cycle et de maximiser l'efficacité. Pour en savoir plus sur Veeva Quality Cloud pour les CDMO, visitez le site veeva.com/eu/Quality-CDMO.À propos de Veeva SystemsVeeva fournit une plateforme cloud pour
More news about: Veeva Systems
May 29, 2026, 10:33 ET Veeva Quality Cloud optimiza las operaciones de fabricación de Kindeva
ciclo y maximizar la eficiencia. Para obtener más información sobre Veeva Quality Cloud para CDMO, visite veeva.com/eu/Quality-CDMO.Acerca de Veeva SystemsVeeva ofrece la plataforma en la nube para el
More news about: Veeva Systems
![PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358](https://mma.prnewswire.com/media/2700185/PharmaLogic_Holdings_Corp_Logo.jpg?w=300){kind=logo}
May 29, 2026, 08:00 ET PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358
PharmaLogic Holdings Corp., ("PharmaLogic" or "the Company"), a leading contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, today announced an expansion of its manufacturing partnership with Ratio Therapeutics Inc. (Ratio), a pharmaceutical
More news about: PharmaLogic Holdings Corp
![Ratio Therapeutics and PharmaLogic Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358](https://mma.prnewswire.com/media/2682145/Ratio_Therapeutics_Logo.jpg?w=300){kind=logo}
May 29, 2026, 08:00 ET Ratio Therapeutics and PharmaLogic Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358
an expanded manufacturing collaboration with PharmaLogic Holdings Corp. (PharmaLogic), a leading contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, to support the continued clinical development and future commercialization readiness of Ratio's lead therapeutic
More news about: Ratio Therapeutics Inc.